Jonathan B. Siegel, Director at Jaguar Health, Inc. (JAGX), bought 5,000 shares at $1.10 ($6K) on 2018-07-18, disclosed to the SEC on 2018-07-20.
Open-market purchase of $6k JAGX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| JAGX | BUY | 2018-10-04 | $319 | — | Filing → |
| JAGX | BUY | 2018-07-18 | $13K | — | Filing → |